A list of Biotech IPOs in 2022, their targets, platforms, indications and lead-candidate stage.
A list of Biotech IPOs in 2021, their targets, platforms, indications and lead-candidate stage.
Drug development landscape in targeting MCL-1.
Drug development landscape in targeting PRMT5.
Drug development landscape in targeting RAS, SOS1 and SHP2 within the mitogenic pathway.
Drug development landscape in the treatment of sickle cell disease.
Drug development landscape in the treatment of spinal muscular atrophy.
Drug development landscape in the treatment of wet age-related macular degeneration.